MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss attributed
to 60 degrees...
-$7,365,158
(7.32%↑ Y/Y)
Net loss
noncontrolling interest
-$3,167
(62.99%↑ Y/Y)
Net loss
-$7,368,325
(7.38%↑ Y/Y)
Change in fair value of
derivative liabilities
$266,089
(115.97%↑ Y/Y)
Other income, net
$131,970
(30.07%↑ Y/Y)
Product revenues net of
discounts and rebates
$1,005,471
(65.49%↑ Y/Y)
Loss from operations
before provision for...
-$7,368,325
(7.38%↑ Y/Y)
Total interest and
other income...
$390,254
(-77.82%↓ Y/Y)
Research revenues
$403,624
(447.13%↑ Y/Y)
Gross profit
$223,776
(0.43%↑ Y/Y)
Interest expense
$7,805
(-1.35%↓ Y/Y)
Cost of revenues
$781,695
(103.16%↑ Y/Y)
Loss from operations
-$7,758,579
(20.14%↑ Y/Y)
Net revenue
$627,400
(111.54%↑ Y/Y)
Total operating
expenses
$8,385,979
(-16.24%↓ Y/Y)
General and
administrative expenses
$6,279,823
(24.97%↑ Y/Y)
Research and development
$2,106,156
(-57.76%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
60 DEGREES PHARMACEUTICALS, INC. (SXTP)
60 DEGREES PHARMACEUTICALS, INC. (SXTP)